1. |
韓德五.肝硬化動物模型研究.山西醫藥雜志, 1979; 4(1)∶1.
|
2. |
王成彬,田亞平,沈文梅等.魯米諾化學發光測定一氧化氮,自由基生命科學進展.北京:原子能出版社,1995∶159.
|
3. |
李振甲,王仁芳主編.激素的放射免疫分析.第1版.北京:科學技術文獻出版社,1985∶138.
|
4. |
嚴濤,張平,孟憲鈞等.熒光素酶系測定組織ATP、ADP、AMP水平的生物發光法.第三軍醫大學學報,1987; 9(6)∶294.
|
5. |
Paul CK, Rebecca AS. The emerging multifaceted role of nitric oxide. Ann Surg, 1995; 221∶220.
|
6. |
Askin DL, Valle MR, Heck DE, et al.Hepatic nitric oxide production following acute endotoxemia in rats is mediated by increased inducible nitric oxide synthase gene expression. Hepatology, 1995; 22(3)∶223.
|
7. |
Beckman JS, Beckman TW, Chen J, et al. Apparent hydroxyl radical production by reroxynitrite:implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA, 1990; 87(8)∶1620.
|
8. |
Billiar TR. The delicate balance of nitric oxide and superoxide in liver pathology. Gastroenterology, 1995; 108(6)∶603.
|
9. |
Bush LR, Campbell WB, Buja LM, et al. Effects of the selective thromboxane synthetase inhinitor dazoxiben on variatious in cyclic blood flow in stenosed canine coronary arteriess. Circulation, 1984; 69(9)∶1161.
|
10. |
Sikujara O, Moden M, Toyoshima K,et al. Cytoprotective effect of prostaglandin I2 on ischemiareperfusion hepatic cell injury. Transpiantantion, 1983; 36(3)∶238.
|
11. |
Marubayashi S, Takenaka M, Dohi K, et al. Adenine nucleotide metabolism during hepatic ischemia and subequent blood reflow periods and its relation to organ viablity. Transplantaion, 1980; 30(3)∶294.
|